In a double-blind, placebo-controlled, cross-over experiment in 21 healthy male volunteers, aged 19 to 27 y, the pharmacokinetics and tolerance of the new anxiolytic drug alpidem (SL80.0342) and its three major metabolites were studied after single doses of 25, 50, 100 and 200 mg. Plasma concentrati
Pharmacokinetics, COX-2 specificity, and tolerability of supratherapeutic doses of rofecoxib in humans
✍ Scribed by M. Depré; E. Ehrich; A. Van Hecken; I. De Lepeleire; A. Dallob; P. Wong; A. Porras; B. J. Gertz; P. J. De Schepper
- Publisher
- Springer
- Year
- 2000
- Tongue
- English
- Weight
- 155 KB
- Volume
- 56
- Category
- Article
- ISSN
- 0031-6970
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Chronic arthritis adversely affects glomerular function and nonsteroidal anti‐inflammatory drugs (NSAIDs) reduce electrolyte urinary excretion. In addition, both acute and chronic inflammations may alter clearance of drugs. We studied (a) the effects of inflammation on the renal functio
Racemic ethotoin (lo00 mg) was administered orally as a single dose to six healthy adult volunteers. Blood samples were collected at appropriate times for 120 h following the dose. Ethotoin was quantified enantioselectively in plasma using a novel chiral column HPLC procedure. One of the enantiomers